A Phase I Trial of ZIO-101 in Solid Tumors
NCT00591396
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
ZIO-101 (Darinaparsin)
Sponsor
Alaunos Therapeutics